E&C Will Consider Rare Disease Bills On IRA, Voucher Program

Ahead of FDA’s annual Rare Disease Day event March 1, the House Energy & Commerce Committee will hold a legislative hearing to consider 18 bills aimed at assisting patients with rare diseases, including legislation reauthorizing FDA’s pediatric rare disease priority review voucher and expanding the number of orphan drugs excluded from the Inflation Reduction Act’s (IRA) Medicare drug price negotiation program. E&C Chair Cathy McMorris Rodgers (R-WA) and health subcommittee Chair Brett Guthrie (R-KY) announced the hearing Friday (Feb. 23)...